Private Equity 3 Days

Last updated: May 17, 2026, 2:31 PM ET

Deal Activity & Take‑Privates Closed merger saw Charlesbank‑backed Tecomet combine with Nordic‑backed Orchid Orthopedic Solutions, creating a unified orthopedic platform under the Tecomet name and adding roughly €1.2bn of annual revenue to the combined entity. A day later, completed acquisition enabled Kinderhook to take Enhabit Home Health & Hospice private in an all‑cash deal valued at $1.9bn, giving Kinderhook a foothold in the rapidly consolidating post‑acute care market. Both transactions underscore private equity’s focus on roll‑up strategies in fragmented health‑service niches, where scale can unlock cost efficiencies and stronger payer negotiations.

Fundraising & Co‑Investments Committed capital from CPP Investments of €400m alongside Blackstone marked a significant co‑investment in French last‑mile logistics platform Proudreed, positioning the vehicle to benefit from e‑commerce‑driven warehouse expansion across Europe. Meanwhile, launched fund saw Meridian Ventures raise $35m to back MBA‑deferred founders building enterprise technology in the United States, reflecting a trend of niche funds targeting founder‑friendly capital structures. Together, these moves illustrate PE firms’ diversification into both sector‑specific growth capital and founder‑led tech bets.

Debt‑Heavy Restructurings Engineered debt cut by a Blackstone‑ and KKR‑led lender consortium will write off roughly 70% of Affordable Care’s $2.3bn debt load, converting the remaining obligations into equity and giving the lenders control of the senior‑living operator. This restructuring mirrors a broader shift toward distressed‑credit strategies that allow PE sponsors to acquire assets at deep discounts while assuming operational risk. The approach aligns with recent private‑equity‑driven turnarounds in the healthcare space, where demographic tailwinds support long‑term upside despite near‑term balance‑sheet stress.

Sector‑Specific M&A Snapped up aerospace coating firm saw HIG Capital acquire International Aerospace Coatings for an undisclosed sum, adding a niche supplier of specialty paints and surface treatments to its portfolio of aerospace‑service assets. In a parallel move, acquired integration specialist Fusion Capital‑backed Relevant purchased Automation Werx, expanding its flow‑control solutions across oil‑and‑gas, chemical and food processing markets. Both deals highlight PE’s appetite for high‑margin, technology‑enabled industrial businesses where recurring service contracts can stabilize cash flow.

Life Sciences & Data Analytics Targeted life‑science consulting saw Blackstone, Audax and Five Arrows eyeing pharmaceutical and life‑science consulting firms, while Eir Partners invested in Quartz Bio to tap data‑analytics capabilities that de‑risk drug‑R&D pipelines. The dual focus on advisory services and proprietary data platforms reflects private equity’s strategy to capture value from the increasing complexity of drug development, where firms that can streamline clinical‑trial design are commanding premium multiples.

Testing, Inspection & Revenue Predictability Focused on TICC deals Ardian, Blackstone, Bridgepoint and EQT each placed capital into testing, inspection, certification and calibration (TICC) companies, citing the sector’s subscription‑style revenue streams and low cyclicality. By targeting firms that provide mandatory compliance services to aerospace, energy and manufacturing clients, PE sponsors are betting on predictable cash flows that can support higher leverage ratios in a low‑interest‑rate environment.

Strategic Exits & Market Realignment Exited China fund unit Schroders agreed to transfer its wholly‑owned China fund management business to Neuberger Berman, effectively exiting a market where regulatory constraints have squeezed foreign asset managers. The move allows Schroders to redeploy capital toward higher‑growth regions, while Neuberger gains a platform to expand its Asia‑focused product suite. This realignment mirrors a broader trend of Western PE and asset managers recalibrating exposure to China amid tightening capital controls.

Private Wealth Integration* Made case for patient capital argued that the extension of private‑equity holding periods and growing retail‑allocation appetite are creating a “private‑wealth moment,” encouraging firms to open feeder vehicles to high‑net‑worth individuals. By extending fund lifespans beyond the traditional 10‑year window, sponsors can capture additional upside from late‑stage growth companies that remain private longer, thereby aligning investor horizons with the increasingly patient nature of modern PE investments.**